Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.40 (-0.65) | AIM:£3.15 (-0.09)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 8 Apr 2024

Preclinical characterization of HMPL-295, a potent and selective ERK1/2 inhibitor